4.8 Article

Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity

期刊

SCIENCE
卷 373, 期 6550, 页码 -

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.abf8683

关键词

-

资金

  1. Regeneron Pharmaceuticals
  2. National Institutes of Health [HL034300, HL139793, HL139793-1S]
  3. UK Medical Research Council
  4. Mexican Health Ministry
  5. Mexican National Council of Science and Technology
  6. Wellcome Trust
  7. British Heart Foundation
  8. Cancer Research UK
  9. Nuffield Department of Population Health at the University of Oxford
  10. National Center for Advancing Translational Sciences, CTSI [UL1TR001881]
  11. National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) [DK063491]

向作者/读者索取更多资源

Large-scale human exome sequencing identified rare protein-coding variants with significant associations with body mass index (BMI), including G protein-coupled receptors. Protein-truncating variants in GPR75 were found to be associated with lower BMI and reduced risk of obesity, suggesting it as a potential therapeutic target for obesity.
Large-scale human exome sequencing can identify rare protein-coding variants with a large impact on complex traits such as body adiposity. We sequenced the exomes of 645,626 individuals from the United Kingdom, the United States, and Mexico and estimated associations of rare coding variants with body mass index (BMI). We identified 16 genes with an exome-wide significant association with BMI, including those encoding five brain-expressed G protein-coupled receptors (CALCR, MC4R, GIPR, GPR151, and GPR75). Protein-truncating variants in GPR75 were observed in similar to 4/10,000 sequenced individuals and were associated with 1.8 kilograms per square meter lower BMI and 54% lower odds of obesity in the heterozygous state. Knock out of Gpr75 in mice resulted in resistance to weight gain and improved glycemic control in a high-fat diet model. Inhibition of GPR75 may provide a therapeutic strategy for obesity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据